# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001140361-25-023395
Filing Date
2025-06-23
Accepted
2025-06-23 17:29:41
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | ny20050076x2_defr14a.htm | DEFR14A | 13236
2 | GRAPHIC | ny20050076x2_pc1.jpg | GRAPHIC | 752450
3 | GRAPHIC | ny20050076x2_pc2.jpg | GRAPHIC | 418699
| Complete submission text file | 0001140361-25-023395.txt |  | 1626659

Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-42204 | Film No.: 251066016
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)